Acessibilidade / Reportar erro

Cortical ribbon sign on neuroimaging in a patient with hepatic encephalopathy secondary to herbal medicine usage

The use of herbal medicines is growing exponentially despite the lack of scientific evidence regarding their effectivity and toxicity. ( 11. Gurley BJ, McGill MR, Koturbash I. Hepatotoxicity due to herbal dietary supplements: Past, present and the future. Food Chem Toxicol. 2022; 169:113445. Review. , 22. Zovi A, Langella R, Nisic A, Vitiello A, Musazzi UM. Liver injury and dietary supplements: Does hydroxycitric acid trigger hepatotoxicity? J Integr Med. 2022;20(5):473-5. Review. ) Moreover, the use of herbal medicines have been reported to be common in patients with chronic liver disease (30–62%); these medicines can lead to hepatotoxicity and serious hepatic side effects. ( 33. Bunchorntavakul C, Reddy KR. Review article: herbal and dietary supplement hepatotoxicity. Aliment Pharmacol Ther. 2013;37(1):3-17. Review. ) Hepatic encephalopathy is a complication of acute liver failure and chronic liver disease that causes cognitive dysfunction, motor deficits, and seizures. ( 44. Weissenborn K. Hepatic Encephalopathy: definition, clinical grading and diagnostic principles. Drugs. 2019;79(Suppl 1):5-9. Review. , 55. Zhang XD, Zhang LJ. Multimodal MR imaging in hepatic encephalopathy: state of the art. Metab Brain Dis. 2018;33(3):661-671. Review. ) Gastrointestinal hemorrhage, infection, dehydration, constipation, and use of medications are the most common precipitating factors. ( 55. Zhang XD, Zhang LJ. Multimodal MR imaging in hepatic encephalopathy: state of the art. Metab Brain Dis. 2018;33(3):661-671. Review. )

This study reports the case of a previously healthy 37-year-old woman who developed acute liver failure and hepatic encephalopathy (international normalized ratio 3.5, total bilirubin 30.2mg/dL, direct bilirubin 15.5mg/dL, aspartate aminotransferase 423U/L, and alanine aminotransferase 459U/L) after consuming an herbal medicine ( Citrus sinensis ) for lose weight. The patient went to the hospital due to jaundice and malaise, being hospitalized for evaluation. She underwent brain magnetic resonance imaging (MRI) due to lethargy, revealing cortical ribbon sign in diffusion-weighted and fluid-attenuated inversion recovery (FLAIR) sequences and hypersignal in the caudate nuclei, putamen, and insula bilaterally ( Figure 1 ). The cortical ribbon sign is a typical finding in patients with Creutzfeldt–Jakob disease; however, it has also been reported in patients with infection, hypoxia, electrolyte derangements, and hepatic encephalopathy (as in the present case). ( 66. Abdulmassih R, Min Z. An ominous radiographic feature: cortical ribbon sign. Intern Emerg Med. 2016;11(2):281-3. , 77. Muir RT, Sundaram AN. Cortical Ribbon Sign in Acute Hepatic Encephalopathy with Sequential Atrophy. Can J Neurol Sci. 2019;46(6):758-9. ) Moreover, magnetic resonance spectroscopy revealed an increase in glutamate/glutamine, typically observed in hepatic encephalopathy ( Figure 2 ). Owing to the severity of the condition, the patient underwent liver transplantation and is improving progressively.

Figure 1
Axial magnetic resonance imaging. (A) FLAIR imaging sequence with hyperintensity involving practically the entire cortical ribbon; (B) Diffusion-weighted imaging sequence with diffusion restriction throughout the cerebral cortex, notably in the bilateral insulae

Figure 2
Proton magnetic resonance spectroscopy positioned in the right insular cortical region, showing glutamate/glutamine peak (increased in hepatic encephalopathy), slight decrease in myo-inosital (glial marker), and lipid/lactate peak (marker of necrosis/anaerobiosis)

REFERENCES

  • 1
    Gurley BJ, McGill MR, Koturbash I. Hepatotoxicity due to herbal dietary supplements: Past, present and the future. Food Chem Toxicol. 2022; 169:113445. Review.
  • 2
    Zovi A, Langella R, Nisic A, Vitiello A, Musazzi UM. Liver injury and dietary supplements: Does hydroxycitric acid trigger hepatotoxicity? J Integr Med. 2022;20(5):473-5. Review.
  • 3
    Bunchorntavakul C, Reddy KR. Review article: herbal and dietary supplement hepatotoxicity. Aliment Pharmacol Ther. 2013;37(1):3-17. Review.
  • 4
    Weissenborn K. Hepatic Encephalopathy: definition, clinical grading and diagnostic principles. Drugs. 2019;79(Suppl 1):5-9. Review.
  • 5
    Zhang XD, Zhang LJ. Multimodal MR imaging in hepatic encephalopathy: state of the art. Metab Brain Dis. 2018;33(3):661-671. Review.
  • 6
    Abdulmassih R, Min Z. An ominous radiographic feature: cortical ribbon sign. Intern Emerg Med. 2016;11(2):281-3.
  • 7
    Muir RT, Sundaram AN. Cortical Ribbon Sign in Acute Hepatic Encephalopathy with Sequential Atrophy. Can J Neurol Sci. 2019;46(6):758-9.

Publication Dates

  • Publication in this collection
    13 Nov 2023
  • Date of issue
    2023

History

  • Received
    27 Mar 2023
  • Accepted
    07 June 2023
Instituto Israelita de Ensino e Pesquisa Albert Einstein Avenida Albert Einstein, 627/701 , 05651-901 São Paulo - SP, Tel.: (55 11) 2151 0904 - São Paulo - SP - Brazil
E-mail: revista@einstein.br